Vincerx Pharma Inc.

OTC: VINC · Real-Time Price · USD
0.05
0.00 (0.00%)
At close: May 19, 2025, 2:31 PM
0.00%
Bid 0.05
Market Cap 251.25K
Revenue (ttm) n/a
Net Income (ttm) -22.64M
EPS (ttm) -15.85
PE Ratio (ttm) n/a
Forward PE n/a
Analyst Buy
Ask 0.05
Volume 218,117
Avg. Volume (20D) 941,219
Open 0.05
Previous Close 0.05
Day's Range 0.05 - 0.05
52-Week Range 0.04 - 17.18
Beta 1.52

About VINC

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VINC
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VINC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
-49.24%
Vincerx Pharma shares are trading lower after the ... Unlock content with Pro Subscription
3 months ago
-5.45%
Vincerx Pharma shares are trading higher after the company and Oqory announced Phase 1a/1b results for Anti-TROP2 ADC OQY-3258 in solid tumors. Additionally, there is a proposed merger between the two companies to advance Phase 2 trials and build an ADC pipeline.